Northwest Biotherapeutics: Funding, Investors & Team (Oct 2026)
Northwest Biotherapeutics is a development stage biotechnology company focused on discovering, developing and commercializing immunotherapy products that generate and enhance immune system responses to treat cancer. The Company operates in the United States and is incorporated in Delaware, USA. Currently approved cancer treatments are frequently ineffective, can cause undesirable side effects and provide marginal clinical benefits. The Company’s approach in developing cancer therapies utilizes its expertise in the biology of dendritic cells, which are a type of white blood cell that activate the immune system. The Company’s cancer therapies have been demonstrated in clinical trials to significantly extend both time to recurrence and survival, whilst providing a superior quality of life with no debilitating side effects when compared with current therapies.
Northwest Biotherapeutics has raised $5.0M across 1 funding round on record, the most recent an undisclosed round of $5.0M announced in Dec 2024.
That round is below the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Northwest Biotherapeutics Company Profile and Key Stats
Latest funding round on record: Dec 2024.
Northwest Biotherapeutics Funding Rounds
Northwest Biotherapeutics Founders and Leadership Team
Contact details for the Northwest Biotherapeutics team: 1 of 1 has an email address on file.
Start 14-day free trial →Northwest Biotherapeutics Funding Compared to Other Biotechnology Startups
Northwest Biotherapeutics' latest round of $5.0M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Northwest Biotherapeutics in Biotechnology and Bethesda
Companies Similar to Northwest Biotherapeutics
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Northwest Biotherapeutics Funding FAQs
What does Northwest Biotherapeutics do?
Northwest Biotherapeutics is a development stage biotechnology company focused on discovering, developing and commercializing immunotherapy products that generate and enhance immune system responses to treat cancer. The Company operates in the United States and is incorporated in Delaware, USA. Currently approved cancer treatments are frequently ineffective, can cause undesirable side effects and provide marginal clinical benefits. The Company’s approach in developing cancer therapies utilizes its expertise in the biology of dendritic cells, which are a type of white blood cell that activate the immune system. The Company’s cancer therapies have been demonstrated in clinical trials to significantly extend both time to recurrence and survival, whilst providing a superior quality of life with no debilitating side effects when compared with current therapies.
How much funding has Northwest Biotherapeutics raised?
Northwest Biotherapeutics has raised $5.0M across 1 round on record. The most recent is an undisclosed round of $5.0M announced in Dec 2024.
When did Northwest Biotherapeutics last raise funding?
Northwest Biotherapeutics' most recent funding round on record is an undisclosed round of $5.0M, announced in Dec 2024.
Who founded Northwest Biotherapeutics?
FundedIQ lists Linda Powers (Founder) at Northwest Biotherapeutics.
Where is Northwest Biotherapeutics headquartered?
Northwest Biotherapeutics is based in Bethesda, Maryland, United States.
How many employees does Northwest Biotherapeutics have?
Northwest Biotherapeutics is in the 11-50 employee band.
How does Northwest Biotherapeutics' funding compare to other Biotechnology startups?
Northwest Biotherapeutics' latest round of $5.0M is below the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Northwest Biotherapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Northwest Biotherapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.